The University of Chicago Header Logo
Last Name


Search Results to Jeremy Segal

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Segal, Jeremy

overview Dr. Segal is a molecular pathologist with a clinical focus on next generation sequencing testing for oncology diagnosis and patient management. He specializes in the development and validation of large-scale genomics assays and bioinformatics systems to support all aspects of personalized oncology practice. His research interests include genomic analysis of tumors, exploratory bioinformatics and the use of genomics to support personalized cellular immunotherapy. Director, Molecular and Cytogenetic Pathology President, Genomics Association for Academic Laboratories

One or more keywords matched the following items that are connected to Segal, Jeremy

Item TypeName
Concept Carcinoma, Renal Cell
Concept Medical Informatics
Concept Pathology, Molecular
Academic Article Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block.
Academic Article Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape.
Academic Article System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.
Academic Article Melanotic Translocation Renal Cell Carcinoma With a Novel ARID1B-TFE3 Gene Fusion.
Academic Article Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?
Academic Article Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.
Academic Article Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma.
Academic Article Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center.
Academic Article Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.
Academic Article Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study.
Academic Article A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion.
Academic Article BAP1-Mutated Clear Cell Renal Cell Carcinoma.
Academic Article TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study.
Academic Article Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case.

Search Criteria
  • Medical
  • Renal
  • Pathology